Further investigation revealed that ZEB1‐AS1 down‐regulation markedly blocked the proliferation and invasion ability, coupled with elevation of E‐cadherin expression and reduces of N‐cadherin and vimentin expressions in ESCC cells. This evidence concerns the gene ZEB1 and esophageal squamous cell carcinoma.